Arrogene Competitors and Similar CompaniesClear all

Arrogene's competitors and similar companies include Advaite, Guardant Health, KEW and 2cureX.

	Arrogene Arrogene is a development stage company that develops nano-biopolymers and related technologies for cancer therapeutics and diagnostics.	Advaite Advaite is a biotech company focused on developing therapeutics and diagnostics to help patients suffering from debilitating diseases.	Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.	KEW KEW is a genomic profiling company specializing in cancer care.	2cureX 2cureX is a biotech company that helps physicians to select an individual drug therapy for their cancer patients.
Founding Date	Founding Date 2007	Founding Date 2017	Founding Date 2012	Founding Date 2011	Founding Date 2006
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy
Locations	Locations West Hollywood, US HQ	Locations Malvern, US HQ Chicago, US	Locations Redwood City, US HQ	Locations Waltham, US HQ Newton, US	Locations Copenhagen, DK HQ Hamburg, DE
Employees	Employees N/A	Employees 5	Employees 1,7681% decrease	Employees 205% increase	Employees 14
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) N/A	Valuation ($) 792.7 k
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $982m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $349m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $633m (FY, 2025)	Gross profit N/A	Gross profit kr10k (FY, 2025)
Net income	Net income ($1m) (FY, 2015)	Net income N/A	Net income ($416.3m) (FY, 2025)	Net income N/A	Net income (kr2.6m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 750k (about 10 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 16.8m (over 11 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 3.7m	Total funding raised N/A	Total funding raised $ 550m	Total funding raised $ 32.9m	Total funding raised N/A